Viralkumar Shah, MD
Endocrinology, Diabetes & Metabolism · Aurora, CONPI 1255762118
Payments from drug & device makers
Across 624 payments — averaging $3338.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$564K
- Tandem Diabetes Care, Inc.$330K
- Novo Nordisk$234K
- Eli Lilly$228K
- Sequel Med Tech, LLC$191K
- Sanofi US Services Inc.$150K
- plus $386K from 18 others
Across 24 payments — averaging $663.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi-aventis U.S. LLC$5K
- Eli Lilly$4K
- Lifescan, Inc.$4K
- Novo Nordisk$2K
- Sanofi US Services Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 69 | $564,049 |
| Tandem Diabetes Care, Inc. | 17 | $330,489 |
| Novo Nordisk | 28 | $234,301 |
| Eli Lilly | 8 | $228,141 |
| Sequel Med Tech, LLC | 141 | $190,764 |
| Sanofi US Services Inc. | 10 | $149,540 |
| Novo Nordisk AS | 185 | $117,394 |
| Dexcom, Inc. | 58 | $94,752 |
| AstraZeneca | 2 | $47,148 |
| Sanofi-aventis U.S. LLC | 26 | $46,355 |
| Embecta Corp. | 10 | $26,106 |
| Medtronic | 27 | $18,144 |
| F. Hoffmann-la Roche AG | 8 | $14,022 |
| Ascensia Diabetes Care US Inc. | 6 | $7,309 |
| Sanofi | 3 | $6,072 |
| Lifescan, Inc. | 9 | $5,101 |
| Abbott | 3 | $2,541 |
| Mannkind Corporation | 5 | $275 |
| Radius Health, Inc. | 4 | $246 |
| BETA Bionics, Inc. | 1 | $109 |
| Roche Diagnostics Corporation | 1 | $70 |
| Boehringer Ingelheim | 1 | $47 |
| Xeris Pharmaceuticals, Inc. | 1 | $31 |
| Rhythm Pharmaceuticals, Inc. | 1 | $23 |
How this compares
$2,083,028 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.
See all endocrinology, diabetes & metabolism providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Aurora
- Satish GargAurora$8.6M
- Neda RasouliAurora$6.7M
- Halis AkturkAurora$1.8M
- Bryan HaugenAurora$714K
- Sarit PolskyAurora$575K
- Marc Andre CornierAurora$475K
- Holly WyattAurora$465K
- Whitney GoldnerAurora$386K
- Peter GottliebAurora$335K
- David SaxonAurora$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.